Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB

Applied and Environmental Microbiology

Volumn 64, Issue 11, 1998, Pages 4573-4580

  Coconnier, Marie Helene ^a   Lievin, Vanessa ^a   Hemery, Elisabeth ^b   Servin, Alain L ^a  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; LACTIC ACID; UREASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BACTERIUM CULTURE; CELL LINE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS ACIDOPHILUS; MOUSE; NONHUMAN; PH; STOMACH; SUPERNATANT;

ANIMALIA; BACTERIA (MICROORGANISMS); FELIS; HELICOBACTER; HELICOBACTER FELIS; HELICOBACTER PYLORI; LACTOBACILLUS ACIDOPHILUS; NEGIBACTERIA; POSIBACTERIA;

EID: 0031765113     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.64.11.4573-4580.1998     Document Type: Article

References (39)

1. Bernet, M. F., D. Brassart, J. R. Neeser, and A. L. Servin. 1994. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell-attachment and cell-invasion by enterovirulent bacteria. Gut 35:483-489.
2. Bernet-Camard, M.-F., V. Liévin, D. Brassart, J.-R. Neeser, A. L. Servin, and S. Hudault. 1997. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 63:2747-2753.
3. Berry, V., K. Jennings, and G. Woodnutt. 1995. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob. Agents Chemother. 39:1859-1861.
4. Bhatia, S. J., N. Kochar, P. Abraham, N. G. Nair, and A. P. Mehta. 1989. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J. Clin. Microbiol. 27:2328-2330.
5. Caternich, C. E., and K. M. Makin. 1991. Characterization of the morphological conversion of Helicobacter pylori from bacillary to coccoid forms. Scand. J. Gastroenterol. 26:58-64.
6. Cellini, L., N. Allocati, D. Angelluci, T. Iezzi, E. Di Campli, L. Marzio, and B. Dainelli. 1994. Coccoid forms of Helicobacter pylori not culturable in vitro reverts in mice. Microbiol. Immunol. 38:843-850.
7. Chauvière, G., M. H. Coconnier, S. Kernéis, A. Darfeuille-Michaud, B. Joly, and A. L. Servin. 1992. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from enterocyte-like Caco-2 cells in culture. FEMS Microbiol. Lett. 91:213-218.
8. Chauvière, G., M. H. Coconnier, S. Kernéis, J. Fourniat, and A. L. Servin. 1992. Adherence of human Lactobacillus acidophilus onto human enterocyte-like cells, Caco-2 and HT-29 in culture. J. Gen. Microbiol. 138:1689-1696.
9. Clyne, M., and B. Drumm. 1996. Cell envelope characteristics of Helicobacter pylori: their role in adherence to mucosal surfaces and virulence. FEMS Immunol. Med. Microbiol. 16:141-155.
10. Clyne, M., A. Labigne, and B. Drumm. 1995. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect. Immun. 63: 1669-1673.
11. Coconnier, M. H., M. F. Bernet, S. Kernéis, G. Chauvière, J. Fourniat, and A. L. Servin. 1993. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett. 110:299-306.
12. Coconnier, M.-H., V. Liévin, M.-F. Bernet-Camard, S. Hudault, and A. L. Servin. 1997. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob. Agents Chemother. 41:1046-1052.
13. Corthésy-Theulaz, I., N. Porta, M. Glauser, E. Saraga, A. C. Vaney, R. Haas, J. P. Kraehenbuhl, A. L. Blum, and P. Michetti. 1995. Oral immunisation with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 109:115-121.
14. Cover, T. L., and M. J. Blaser. 1995. Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. ASM News 61:21-26.
15. Donaldson, R. M., Jr., and P. P. Toskes. 1989. The relationship of enteric populations to gastrointestinal function and disease, p. 107-113. In M. H. Sleisenger and J. S. Fordtran (ed.), Gastrointestinal disease. W. B. Saunders, Philadelphia, Pa.
16. Draser, B. S. 1989. The bacterial flora of the stomach and small intestine. Gastroenterol. Clin. Biol. 13:18B-20B.
17. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.
18. Eaton, K. A., C. E. Caternich, K. M. Makin, and S. Krakowka. 1995. Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets. J. Infect. Dis. 171:459-462.
19. Enno, A., J. L. O'Rourke, C. R. Howlett, A. Jack, M. F. Dixon, and A. Lee. 1995. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis: a mouse model of Helicobacter pylori-induced gastric lymphoma. Am. J. Pathol. 147:217-222.
20. Finlay, B. B., and S. Falkow. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-169.
21. Fogh, J., J. M. Fogh, and T. Orfeo. 1977. One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59:221-226.
22. Hudault, S., V. Liévin, M.-F. Bernet-Camard, and A. L. Servin. 1997 Antagonistic activity in vitro and in vivo exerted by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 63:513-518.
23. Jack, R. W., J. R. Tagg, and B. Ray. 1995. Bacteriocins of gram-positive bacteria. Microbiol. Rev. 59:171-200.
24. Kabir, A. M. A., Y. Aiba, A. Takagi, S. Kamiya, T. Miwa, and Y. Koga. 1997. Prevention of Helicohacler pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41:49-55.
25. Klaenhammer, T. R. 1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12:39-86.
26. Kuster, J. G., M. M. Gerrits, J. A. G. van Strijp, and C. M. J. E. Vandenbrouke-Grauls. 1997. Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect. Immun. 65:3672-3679.
27. Labigne, A., and H. de Reuse. 1996. Determinants of Helicobacter pylori pathogenicity. Infect. Agents Dis. 5:191-202.
28. Lesuffleur, T., A. Barbat, E. Dussaulx, and A. Zweibaum. 1990. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res. 50:6334-6343.
29. Mastrantonio, P., A. Pantosti, M. Cerquetti, C. Fiorentini, and G. Donelli. 1996. Clostridium difficile: an update on virulence mechanisms. Anaerobe 2: 337-343.
30. McGowan, C. C., T. L. Cover, and M. J. Blaser. 1996. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 110: 926-938.
31. Michetti, P., I. Corthesy-Theulaz, C. Davin, R. Haas, A. C. Vaney, M. Heitz, J. Bille, J. P. Kraehenbuhl, E. Saraga, and A. L. Blum. 1994. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 107:1002-1011.
32. Michetti, P., G. Dorta, D. Brassart, D. Vouillamoz, W. Schwitzer, C. Felley, A. L. Blum, N. Porta, M. Rouvet, and I. Corthesy-Theulaz. 1995. L. acidophilus supernatant as an adjuvant in the therapy of H. pylori in humans. Gastroenterology 108:A166.
33. Midolo, P. D., J. R. Lambert, R. Hull, F. Luo, and M. L. Grayson. 1995. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol. 79:475-479.
34. Mohammadi, M., R. Redline, J. Nedrud, and S. Czinn. 1996. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect. Immun. 64:238-245.
35. Moyen, E. N., F. Bonneville, and J. L. Fauehère. 1986. Modification of intestinal colonization and translocation of Campylobacter jejuni in gnotobiotic mice by erythromycin or heat-killed Lactobacillus. Ann. Inst. Pasteur 137:199-207.
36. Sakagami, T., M. Dixon, J. L. O'Rourke, R. Howlett, F. Alderuccio, J. Vella, T. Shimoyama, and A. Lee. 1996. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 39:639-648.
37. Sears, C. L., and J. B. Kaper. 1996. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60:167-215.
38. Silva, M., N. V. Jacobus, C. Deneke, and S. L. Gorbach. 1987. Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 31:1231-1233.
39. Vandenbergh, P. A. 1993. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol. Rev. 12:221-238.